Acute effects of VPX Meltdown® on plasma catecholamines, free fatty acids, glycerol, metabolic rate, and hemodynamics in young men and women by Bloomer, Richard et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Journal of the International Society 
of Sports Nutrition
Open Access Poster presentation
Acute effects of VPX Meltdown® on plasma catecholamines, 
free fatty acids, glycerol, metabolic rate, and hemodynamics in 
young men and women
Richard Bloomer*, Brian Schilling, Robert Canale, Megan Blankenship, 
Kelley Hammond and Kelsey Fisher-Wellman
Address: Cardiorespiratory/Metabolic Laboratory, Department of Health and Sport Sciences, The University of Memphis, Memphis, TN 38152, 
USA
Email: Richard Bloomer* - rbloomer@memphis.edu
* Corresponding author    
Background
We have recently reported that the dietary supplement
Meltdown®  (Vital Pharmaceuticals) increases plasma
norepinephrine (NE), epinephrine (EPI), glycerol, and
free fatty acids (FFA), as well as metabolic rate in healthy
men [1]. However, in that investigation measurements
ceased at 90 minutes post ingestion, with values for
bloodborne variables peaking at this time. It was the pur-
pose of the present investigation to extend the time course
of post ingestion measurement to 6 hours.
Methods
Ten exercise trained men (age = 24 ± 4 yrs; BMI = 25 ± 3
kg·m-2; body fat = 9 ± 3%; mean ± SD) and 10 exercise
trained women (age = 22 ± 2 yrs; BMI = 23 ± 3 kg·m-2;
body fat = 23 ± 5%; mean ± SD) ingested Meltdown® or a
placebo, in a random order, double blind cross-over
design, with one week separating conditions. Blood sam-
ples were collected before and at one hour intervals
throughout the 6 hour protocol. Samples through the 3
hour post ingestion period were obtained in a fasted state
and a standard meal was provided after the hour 3 collec-
tion. Blood samples were assayed for EPI, NE, glycerol,
and FFA. Breath samples were collected at each time for
measurement of metabolic rate and substrate utilization
using indirect calorimetry. Area under the curve (AUC)
was calculated for all variables. Heart rate and blood pres-
sure were recorded at all collection times, and data were
analyzed using a 2 (condition) × 7 (time) analysis of var-
iance.
Results
AUC was greater for Meltdown® compared to placebo for
EPI (367 ± 58 pg·mL-1·6 hr-1 vs. 183 ± 27 pg·mL-1·6 hr-1;
p = 0.01), NE (2345 ± 205 pg·mL-1·6 hr-1 vs. 1659 ± 184
pg·mL-1·6 hr-1; p = 0.02), glycerol (79 ± 8 g·mL-1·6 hr-1
vs. 59 ± 6 g·mL-1·6 hr-1; p = 0.03), and FFA (2.46 ± 0.64
mmol·L-1·6 hr-1 vs. 1.57 ± 0.42 mmol·L-1·6 hr-1; p =
0.05). For all variables, values were highest between 1 and
3 hours post ingestion of Meltdown®. The AUC for kilocal-
orie expenditure was not statistically different (p = 0.12)
for Meltdown® (449 ± 29 kcal·6 hrs-1) compared to pla-
cebo (392 ± 21 kcal·6 hrs-1), despite being 15% higher for
Meltdown®. However, when only considering the AUC for
kilocalorie expenditure from rest to hour 3 (prior to feed-
ing), a difference was noted (p = 0.05) for Meltdown® (224
± 14 kcal·3 hrs-1) compared to placebo (187 ± 10 kcal·3
hrs-1). No difference (p = 0.32) was noted in AUC for sub-
strate utilization between Meltdown® (4.83 ± 0.09·6 hrs-1)
and placebo (5.04 ± 0.15·6 hrs-1). A condition main effect
was noted for both systolic and diastolic blood pressure (p
< 0.0001), with values increasing from a resting 111 ± 2/
69 ± 2 mmHg to a peak of 124 ± 2/75 ± 2 mmHg at hour
3 with Meltdown®, while no change was noted for placebo.
A condition main effect was noted for heart rate (p = 0.01),
with values increasing from a resting 57 ± 2 bpm to a peak
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of 63 ± 2 bpm at hour 5 with Meltdown®, while no change
was noted for placebo.
Conclusion
Ingestion of Meltdown® results in an increase in catecho-
lamine secretion, markers of lipolysis, and metabolic rate
in young men and women. An increase in hemodynamic
variables is also noted, likely due to the catecholamine
response to treatment. Intervention studies should be
undertaken to determine the impact of this dietary sup-
plement on weight/fat loss, while monitoring hemody-
namic variables to ensure safety of treatment.
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